1016 related articles for article (PubMed ID: 16094107)
21. Impact of dysphagia on quality of life after treatment of head-and-neck cancer.
Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett A; Barloon J; Sallah S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):772-8. PubMed ID: 15708256
[TBL] [Abstract][Full Text] [Related]
22. Clinical predictors of quality of life in patients with head and neck cancer.
Terrell JE; Ronis DL; Fowler KE; Bradford CR; Chepeha DB; Prince ME; Teknos TN; Wolf GT; Duffy SA
Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):401-8. PubMed ID: 15096421
[TBL] [Abstract][Full Text] [Related]
23. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.
Cannady SB; Lee WT; Scharpf J; Lorenz RR; Wood BG; Strome M; Lavertu P; Esclamado RM; Saxton JP; Adelstein DJ
Head Neck; 2010 Mar; 32(3):348-56. PubMed ID: 19672875
[TBL] [Abstract][Full Text] [Related]
24. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
25. Chemoradiation for metastatic SCCA: role of comorbidity.
Hathaway B; Johnson JT; Piccirillo JF; Snyderman CH; Wagner RL; Labriola S; Myers EN
Laryngoscope; 2001 Nov; 111(11 Pt 1):1893-5. PubMed ID: 11801964
[TBL] [Abstract][Full Text] [Related]
26. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
Santos AB; Cernea CR; Inoue M; Ferraz AR
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
[TBL] [Abstract][Full Text] [Related]
27. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
Allal AS; Nicoucar K; Mach N; Dulguerov P
Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
[TBL] [Abstract][Full Text] [Related]
28. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
29. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK
Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283
[TBL] [Abstract][Full Text] [Related]
30. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
31. Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide.
Porceddu SV; Sidhom M; Foote M; Burmeister E; Stoneley A; El Hawwari B; Milross C; Kenny L; Poulsen M; Coman WB
J Med Imaging Radiat Oncol; 2008 Oct; 52(5):491-6. PubMed ID: 19032396
[TBL] [Abstract][Full Text] [Related]
32. Impact of neck dissection on quality of life.
Kuntz AL; Weymuller EA
Laryngoscope; 1999 Aug; 109(8):1334-8. PubMed ID: 10443845
[TBL] [Abstract][Full Text] [Related]
33. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
34. Acceptance of major surgical procedures and quality of life among long-term survivors of advanced head and neck cancer.
Vartanian JG; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):376-9. PubMed ID: 19380360
[TBL] [Abstract][Full Text] [Related]
35. Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.
Le QT; Taira A; Budenz S; Jo Dorie M; Goffinet DR; Fee WE; Goode R; Bloch D; Koong A; Martin Brown J; Pinto HA
Cancer; 2006 May; 106(9):1940-9. PubMed ID: 16532436
[TBL] [Abstract][Full Text] [Related]
36. Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma.
Igidbashian L; Fortin B; Guertin L; Soulières D; Coulombe G; Belair M; Charpentier D; Tabet JC; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):414-20. PubMed ID: 19775825
[TBL] [Abstract][Full Text] [Related]
37. Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer.
Frowen J; Cotton S; Corry J; Perry A
Head Neck; 2010 Apr; 32(4):513-28. PubMed ID: 19691115
[TBL] [Abstract][Full Text] [Related]
38. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment.
Denittis AS; Machtay M; Rosenthal DI; Sanfilippo NJ; Lee JH; Goldfeder S; Chalian AA; Weinstein GS; Weber RS
Am J Otolaryngol; 2001; 22(5):329-35. PubMed ID: 11562884
[TBL] [Abstract][Full Text] [Related]
39. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
[TBL] [Abstract][Full Text] [Related]
40. Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer.
Mehanna HM; Morton RP
Clin Otolaryngol; 2006 Jun; 31(3):204-11. PubMed ID: 16759240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
